-
14635-500
(S)-10-hydroxy-Camptothecin-500 mg
Price: $1,062.10List Price: $1,180.11An inhibitor of topoisomerase I that demonstrates less toxicity than its parent compound demonstrates strong anti-tumor activity against a wide range of experimental tumors including L1210 leukemia cells (IC<sub>50</sub> = 1.15 &muM). -
14411-1
(S)-3,5-DHPG-1 mg
Price: $137.36List Price: $152.62An agonist of the group mGluR, binding both mGluR1a and mGluR5a (Ki = 0.9 and 3.9 µM, respectively) but not ionotropic glutamate receptors. -
14411-10
(S)-3,5-DHPG-10 mg
Price: $416.57List Price: $462.85An agonist of the group mGluR, binding both mGluR1a and mGluR5a (Ki = 0.9 and 3.9 µM, respectively) but not ionotropic glutamate receptors. -
14411-5
(S)-3,5-DHPG-5 mg
Price: $278.33List Price: $309.25An agonist of the group mGluR, binding both mGluR1a and mGluR5a (Ki = 0.9 and 3.9 µM, respectively) but not ionotropic glutamate receptors. -
11417-50
(S)-3-Oxo-cyclopentaneacetic acid methyl ester-50 mg
Price: $187.76List Price: $208.62A synthetic intermediate useful for pharmaceutical synthesis. -
11418-50
(S)-3-Oxo-cyclopentanecarboxylic acid methyl ester-50 mg
Price: $187.76List Price: $208.62A synthetic intermediate useful for pharmaceutical synthesis. -
17546-1
(S)-a-Methylbenzyl Ricinoleamide-1 mg
Price: $77.11List Price: $85.68A fatty acid amide derived from ricinoleic acid and methyl benzylamine that demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate -
17546-10
(S)-a-Methylbenzyl Ricinoleamide-10 mg
Price: $460.11List Price: $511.24A fatty acid amide derived from ricinoleic acid and methyl benzylamine that demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate -
17546-25
(S)-a-Methylbenzyl Ricinoleamide-25 mg
Price: $941.95List Price: $1,046.61A fatty acid amide derived from ricinoleic acid and methyl benzylamine that demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate -
17546-5
(S)-a-Methylbenzyl Ricinoleamide-5 mg
Price: $307.05List Price: $341.17A fatty acid amide derived from ricinoleic acid and methyl benzylamine that demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate -
9000336-1
(S)-Acenocoumarol-1 mg
Price: $298.21List Price: $331.34An enantiomer of the short-lived oral anti-coagulant acenocoumarol with a shorter plasma elimination half-life (1.8 hours) and faster plasma clearance (28. -
9000336-10
(S)-Acenocoumarol-10 mg
Price: $1,814.81List Price: $2,016.46An enantiomer of the short-lived oral anti-coagulant acenocoumarol with a shorter plasma elimination half-life (1.8 hours) and faster plasma clearance (28.